Antioxidant treatment normalizes nitric oxide production, renal sodium handling and blood pressure in experimental hyperleptinemia
- 26 August 2005
- journal article
- Published by Elsevier in Life Sciences
- Vol. 77 (15) , 1855-1868
- https://doi.org/10.1016/j.lfs.2005.02.013
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Effects of aortic coarctation on aortic antioxidant enzymes and NADPH oxidase protein expressionLife Sciences, 2005
- Effects of Local Administrations of Tempol and Diethyldithio-Carbamic on Peripheral Nerve ActivityHypertension, 2004
- Oxidative stress, nitric oxide production, and renal sodium handling in leptin-induced hypertensionLife Sciences, 2004
- Role of Reactive Oxygen Species in Endothelin-Induced HypertensionHypertension, 2003
- Oxidative Stress in Arterial HypertensionHypertension, 2001
- Statins as antioxidant therapy for preventing cardiac myocyte hypertrophyJournal of Clinical Investigation, 2001
- Pathophysiological role of leptin in obesity-related hypertensionJournal of Clinical Investigation, 2000
- Endothelin-1 Induces NAD(P)H Oxidase in Human Endothelial CellsBiochemical and Biophysical Research Communications, 2000
- Two-Week Administration of Tempol Attenuates Both Hypertension and Renal Excretion of 8-Iso Prostaglandin F 2αHypertension, 1999
- Leptin and the Renin-Angiotensin-Aldosterone SystemHypertension, 1998